Walleye Capital
TBPH icon

Walleye Capital’s Theravance Biopharma TBPH Stock Holding History

Walleye Capital’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-29,395
Closed -$429K – 5183
2025
Q3 		$429K Sell
29,395
-5,264
-15% -$66.5K ﹤0.01% 2740
2025
Q2 		$382K Buy
+34,659
New +$337K ﹤0.01% 2864
2023
Q1 		– Hold
0
– – – 4630
2022
Q4 		– Hold
0
– – – 3819
2022
Q3 		– Sell
-82,758
Closed -$775K – 3690
2022
Q2 		$750K Buy
82,758
+44,958
+119% +$414K 0.02% 799
2022
Q1 		$361K Buy
+37,800
New +$370K 0.01% 1199
2021
Q3 		– Sell
-16,688
Closed -$242 – 1819
2021
Q2 		$242 Buy
+16,688
New +$313K 0.01% 1014

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.43B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.1B AUM 12.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return